Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Acute Otitis Media Treatment Market, by Drug Type (Antibiotics, Nonsteroidal anti-Inflammatory drug, Analgesic, and Anaesthetic), By Formulation (Oral, and Topical), By End User (Hospitals, Retail pharmacies, and Online pharmacies) and Region - Global Trends, and Forecast to 2025

Published Date : Feb 2018

Acute Otitis Media Treatment Market - Insights Acute otitis media (AOM) is a type of ear infection in which air-filled space behind the eardrum (the middle ear) is infected and causes pain and general symptom

Coherent Market Insights
Facial Injectables Market, by Product Type (Dermal Fillers, and Anti-wrinkle Injection), by Application (Wrinkle Reduction, Facelift, Lip Enhancement, and Others) by End User (Hospitals, Dermatology Centers, Beauty Clinics, and Others), and by Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Facial Injectables Market – Restoring the Radiance of Youth Facial injectable aid in rejuvenating facial skin by reducing or eliminating wrinkles, raising scar depressions, and enhancing lips. Facial i

Coherent Market Insights
Empty Capsules Market, by Product Type (Gelatin Capsules (Porcine, Bovine, Bone Meal), Non-Gelatin Capsules (HPMC, Pullulan)), By Application (Antibiotics, Vitamins, Anti-Inflammatory, Anti-Anemic and Others), By End User (Pharmaceutical Manufacturers, Nutraceutical Manufacturers and Others), and Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Empty Capsules Market - Insights Capsules offer a viable alternative to tablets as an oral delivery of therapeutic compounds. Empty capsules are oral dosage forms, which based on the type of manufacturing mat

Coherent Market Insights
Multiple Sclerosis Therapeutics Market, by Drug Class (Beta Interferon, Corticosteroids, Monoclonal Antibodies, Antineoplastic Agents and Others), by Route of Administration (Oral and Injection), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce), and by Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Multiple Sclerosis Therapeutics Market – Offering Long-term Disease Management Multiple sclerosis (MS) is a disabling autoimmune disease affecting the brain and the spinal cord, eventually causing nerv

Coherent Market Insights
Depression Therapeutics Market, by Drug Type (Selective Serotonin Reuptake Inhibitors (SSRIs), Selective Norepinephrine Reuptake Inhibitors (SNRIs), and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Depression Therapeutics Market - Insights Antidepressants are used to treat a wide range of mental disorders, including depression, anxiety, and major depressive disorder. Certain neurotransmitters in the bra

Coherent Market Insights
Hereditary Angioedema Market, by Drug Class (C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens, and Others), by Route of Administration (Subcutaneous, Intravenous, and Oral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce) and by Region - Global Trends and Forecast till 2025

Published Date : Feb 2018

Hereditary Angioedema Market – Efficient Disease Management for Orphan Disease Hereditary angioedema (HAE) is a rare disorder related with the immune system. The life-threatening condition is caused du

Coherent Market Insights
Prostate Cancer Therapeutics Market, by Drug Type (Hormonal Therapy, Anti-androgens, Immunotherapy, Targeted Therapy, and Chemotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and by Geography - Global Trends, and Forecast to 2025

Published Date : Jan 2018

Prostate Cancer Therapeutics Market Insights Prostate cancer is caused by the uncontrolled growth of the cells in the prostate gland. Prostate cancer is the most common cancer in men in the U.S., after skin c

Coherent Market Insights
Crohn's Disease Treatment Market, by Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators & Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacy and e-Commerce), and by Region - Global Forecast to 2026

Published Date : May 2018

Crohn’s Disease Treatment Market – Global Insights Crohn’s disease is a form of inflammatory bowel disease (IBD) that refers to a chronic inflammatory condition of the gastrointestinal tract

Coherent Market Insights
U.S. Influenza Vaccines Market, by Vaccine Type (Trivalent Vaccines and Quadrivalent Vaccines), by Virus Type (Influenza Virus Type A and Influenza Virus Type B) and by Age Group (Pediatrics and Adults) - Trends, and Forecast till 2025

Published Date : Dec 2017

U.S. Influenza Vaccines Market– Prevention of Virus through Vaccination Aids in Reducing Burden of the Disease Influenza is an infection caused by influenza virus and is commonly known as flu. Vaccinati

Coherent Market Insights
Middle East Tapentadol Market, by Therapeutic Application (Pain Management (Neuropathic Pain, Cancer Pain, and Others), and Cough Treatment), and by Countries - Trends and Forecast to 2025

Published Date : Nov 2017

Tapentadol - Become Pain Free! Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative

Coherent Market Insights
U.S. Opioids Market, By Drugs (Codeine, Fentanyl, Meperidine, Methadone, Morphine, and Hydrocodone) and Therapeutic Application (Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, and Others), Cough Treatment, and Diarrhea Treatment) and by Geography - Trends and Forecast to 2025

Published Date : Nov 2017

Opioids Crisis – Public Health Emergency Opioids are the class of drugs that include illicit drugs such as heroin, codeine, fentanyl, meperidine, methadone, morphine, hydrocodone, diphenoxylate, hydromo

Coherent Market Insights
Hypopharyngeal Cancer Treatment Market by Drug Type (Chemotherapy (Taxol, Taxtere and Methotrexate), Targeted Therapy, by Distribution Channel (Retail Pharmacies, Hospital Pharmacies and Online Pharmacies) - Size, Share, Outlook and Opportunity Analysis 2018 - 2026

To Be Published : Oct 2018

Hypopharyngeal cancer is the malignant tumor initiated in the cells of hypopharynx. Malignant cell of the hypopharyngeal cancer can metastasis into cervical lymph nodes, pharyngeal muscles, cranial nerves, laryn

Coherent Market Insights
Deferiprone Market, by Dosage Form (Tablets, Oral Solutions, and Capsules), by Application (Transfusional Iron Overload and NTDT Caused Iron Overload), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Oct 2018

Deferiprone is an FDA approved drug that is majorly used to treat transfusion-dependent thalassemia and a wide range of disorders. Deferiprone is a type of hydroxypyridinone iron chelator that was synthesized by Dr. Kontoghiorghes in the early mid-1980s. I

Coherent Market Insights
Apixaban Market, by Dosage Form (Capsule and Tablets), Distribution Channel (Hospitals, Clinics, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 - 2026

To Be Published : Oct 2018

Apixaban is a Food and Drug Administrator (FDA) approved anticoagulant used for the treatment of venous thromboembolic events (blood clot) that forms within a vein. Venous thromboembolic events (VTE) can occur

Coherent Market Insights
Orlistat Market, by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), by Region (North America, Europe, Latin America, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Oct 2018

Orlistat is a drug designed to treat obesity. Primary function of Orlistat is to prevent absorption of fat from the diet consumed by humans. It prevents absorption of fats by acting as lipase inhibitors, which eventually reduce the calorie

Coherent Market Insights
Intraocular Melanoma Treatment Market, by Treatment (Targeted Therapy (Rituximab (Rituxan), Ibritumomab (Zevalin), Imatinib (Gleevec), and sorafenib (Nexavar)), Other Therapies), by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and by Geography - Size, Share, Outlook, and Opportunity Analysis 2018-2026

To Be Published : Oct 2018

Intraocular (uveal) melanoma is a rare eye cancer, characterized with blurred vision or a dark spot on the iris. Various treatment options are available for intraocular melanoma, such as eye examinations. According to the National Cancer In

Coherent Market Insights
Nanostructured Drug Market, by Technology, (Nanoparticles, Nanocrystals, Nanotubes, Liposomes, Micelles, and Others), by Applications (Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Oct 2018

Nanotechnology is an emerging field of science that involves atomic or molecular level manipulation of matter. A nanometer is equals to 1 billionth of a meter. Nanotechnology has various application in different fields such as chemical sens

Coherent Market Insights
Phenylalanine Market, by Type (L-phenylalanine, D-Phenylalanine and DL-phenylalanine), by Application (Depression, Chronic Pain, and Vitiligo), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Geography - Size, Share, Outlook, and Opportunity Analysis 2018-2026

To Be Published : Oct 2018

Phenylalanine is essential alpha amino acid, which functions to maintain adequate levels of monoamine neurotransmitters in the brain, thereby maintaining balanced moods. Deficiency of phenylalanine causes mental confusion, depression, reduc

Coherent Market Insights
Fallopian Tube Cancer Market, by Type of Treatment (Therapy and Surgery), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, share, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : Oct 2018

Cells in the body divide and grow to replace damaged and old cells. Cell growth is highly regulated and when sufficient amount of cells are produced to replace the old ones, the division of normal cells is stopped. Regulation error in the c

Coherent Market Insights
Lidocaine Patches Market by Strength of Active Ingredient (5%, 4%, and Others), by Adhesive Material (Aqueous and Non-Aqueous), by Application (Back Pain, Neck Pain, Shoulder Pain, Knees & Elbow Pain, and Others) by End User (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region - Size, Share, Outlook and Opportunity Analysis 2018-2026

To Be Published : Oct 2018

Lidocaine is an aminoethylamide local and topical anesthetic medication, causing temporary numbness or loss of sensation in the area of application. Lidocaine blocks the voltage-gated sodium channels of nerve membranes, thereby preventing the generatio

Coherent Market Insights
Tamoxifen Market, by Dosage Form (Powder, Capsule, Oral Solution, and Tablets), by Indication (Breast Cancer and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -Size, Share, Outlook, and Opportunity Analysis 2018-2026

To Be Published : Oct 2018

Tamoxifen is a type of selective estrogen receptor modulator (SERM) indicated for the treatment of women with high risk of breast cancer. Since its approval in 1998, tamoxifen has been used to treat millions of patients diagnosed with hormo

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.